��������

The Research and Development team at Veraxa Biotech focuses on leveraging innovative methodologies to explore and enhance the capabilities of antibody screening. By integrating cutting-edge techniques in microfluidics and functional assessment, the team members—ranging from scientists to engineers—collaborate to identify and develop novel antibodies with therapeutic potential, thereby driving advancements in immunotherapy and biotechnology.